Regentime is known to be the safest stem cell therapy to treat degenerative, immune, and aging diseases.
Regentime presents 3 anti-aging protocols: Rejuvenation, Fitness, and Athleticism. Diseases involving the cardiovascular, respiratory, gastrointestinal, endocrine, nervous, reproductive, urinary, and musculoskeletal systems are treated as well.
The Regentime procedure is specifically tailored to each case, and has been refined over the past 2 decades, successfully treating thousands of conditions.
History
The Regentime procedure was founded by doctor Nassim Abi Chahine, a Lebanese neurosurgeon and European board holder with a Polish medical doctorate since 2002. At the age of 30, he was the first specialist to start researching, developing, and regularly applying bone marrow autografts for organ regeneration. In 2014, the Regentime® procedure was registered with a trademark ID number 168469 as an intellectual property at the Lebanese Ministry of Economy. Doctor Abi Chahine launched his procedure at the BIT’s 8th World Congress of Regenerative Medicine & Stem Cells in Shanghai, China.
Clinical Neurologist, subspecialist in Neurorehabilitation
Rita T. Boulos
Medical Doctor, fellow in Neurology
Vanessa J. Mansour
Medical Laboratorian, MS in Infectious Diseases and Immunology
Cynthia F. Najjoum
Medical Laboratorian, MS in Infectious Diseases and Immunology
Elsa A. Asmar
Biochemist, MS in Functional Genomics and Proteomics
Ambassadors
An ambassador of the Regentime Procedure is an international person who experienced the benefits of the procedure and decided to help diffuse the knowledge about it worldwide.
